Home » Topics » Regulatory

Regulatory
RSS

FDA approves low-dose Estratab for osteoporosis

March 13, 1998

FDA approves three-day treatment option for bacterial vaginosis

March 12, 1998

Diovan HCT approved in U.S.

March 11, 1998

FDA approves ocular antiinflammatory agent

March 11, 1998

Cipro HC approved for otitis

March 10, 1998

First approval for RPR's new combination patch

March 10, 1998

New cisapride formulation introduced in U.K.

March 9, 1998

Once-a-day Cozaar introduced in Canada

March 9, 1998

New indication for Mobic cleared by U.K. authorities

March 6, 1998

FDA approves expanded indications for Dynabac

March 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...